<?xml version="1.0" encoding="UTF-8"?>
<p>Tomato fruits present a more feasible plant material for developing oral NoV vaccines as they are more palatable than raw potato tubers, and their production and processing have been well established by the food industry [
 <xref ref-type="bibr" rid="CR000831">31</xref>]. Oral delivery of four doses of 0.4 g freeze-dried tomatoes (containing 40 Î¼g VLP) stimulated strong serum anti-NVCP IgG and intestinal mucosal IgA responses in more than 80 % of mice [
 <xref ref-type="bibr" rid="CR0008139">139</xref>]. Furthermore, 100 % of mice developed strong systemic and mucosal antibody responses when a higher dosage (0.8 g per dose) of transgenic tomato was used [
 <xref ref-type="bibr" rid="CR0008138">138</xref>].
</p>
